Post removed.Why?

Aiyo why LoseSSP post already will repost the same thing again at later time? She forgot she posted at earlier time? So fast dementia already?

Posted by WinSSP > 9 seconds ago | Report Abuse

Aunty Atk kasihan ada dementia….
----------------------------------------------------------------

Cha cha aunty LoseSSP what is your average entry price again? Dementia and forget already? ATK help you to recall ok? So funny.... Kikiki....




Posted by Stocksafeplayer > Mar 19, 2021 4:25 PM | Report Abuse

Congrats.......
My average is 4.50....Super grateful aldy!!
-----------------------------

Posted by Stocksafeplayer > Apr 21, 2021 5:45 PM | Report Abuse

My average is 4.20....4.68 too expensive la
----------------------------

Posted by Stocksafeplayer > Sep 1, 2021 4:31 PM | Report Abuse

Average 4.00…. at 5.05… already more than 250k profit on paper… heng ahh!

----------------------------

Posted by shareinvestor888 > Jan 27, 2022 6:39 PM | Report Abuse

I bought GenB at 3.50…. Very happy….

Posted by WinSSP > 3 minutes ago | Report Abuse

When red happens, han tu Aunty Atk appears sampat talk… Hahaha. Thanks for sharing latest news @ETTUSA
--------------------------------------------------

As usual, cha cha aunty always jealous of ATK. See the profile picture? Its a man lah... man become woman... cha cha aunty has both dementia and serious eyesight problems? LoseSSP is also an oldman like Amboi oldman? No wonder birds of same feathers flock together. Kekeke....

I enjoy DJ Tiesto's music.

"Staying Alive", "Staurday Night Fever"... those are baby boomers era of music and movies. Kekeke....

BTW I swear to God and Hell that I am still below fifty years old. Usually teenager or below will call me uncle, thats fine. I never hear before baby boomers calling me uncle. Real become fake, young become old.... Fake become real, old become young..... Only thru the delusional lens and foul mouth of a cha cha aunty. Hahaha.

Posted by WinSSP > 14 minutes ago | Report Abuse

below 5 better
-------------------------------------

Of course better for professional cha cha dancers. 4 rounds of successful GenB trades this year.

Posted here last night that LKT selling his GenB shares in large volumes daily. Smart traders would have cleared their balance this morning. The dumb fake investor whose average prices can auto drop from 4.50, 4.20, 4.00, 3.50, etc can even give delusional talk abt M&A of GenB at high price.

KIEN HUAT INTERNATIONAL LIMITED (a substantial shareholder) disposed 2,692,500 shares on 08-Jun-2022.

KIEN HUAT REALTY SDN BERHAD (a substantial shareholder) disposed 3,026,800 shares on 07-Jun-2022.

KIEN HUAT REALTY SDN BERHAD (a substantial shareholder) disposed 2,357,700 shares on 03-Jun-2022.

KIEN HUAT REALTY SDN BERHAD (a substantial shareholder) disposed 1,200,000 shares on 02-Jun-2022.

KIEN HUAT INTERNATIONAL LIMITED (a substantial shareholder) disposed 20,000,000 shares on 07-Jun-2022.
------------------------------------

OMG what is LKT doing??? Really unexpected!

https://www.asiaone.com/lifestyle/i-want-refund-woman-unhappy-find-closed-rides-and-limited-food-options-uss

Wait... I spotted something strange. Taurx is phrasing the words like this: "decline at a rate substantially less than is typical in Alzheimer’s based on published research."

This statement means that Taurx is comparing their active dose patient's performance in Lucidity trial VS the historical average score for all the placebo patients' for all the previous phase 3 clinical trials done by all other drug companies. I have been attending Taurx's AGMs every year, I have seen this term being used in Taurx's AGM's slides and I am able to comprehend what this announcement statement's phrasing actual meaning.

If Taurx is comparing their active dose's patient performance VS their own trial placebo patient group like in a phase 3 clinical trial scenario, the sentence phrasing should be read as: "decline at a rate substantially less than the trial's placebo patient group."

My personal view is that most likely Lucidity's placebo patient group somehow strangely has a stronger performance when compared to the historical average performance of all the previous phase 3 trials placebo patient group. Lucidity's placebo patient group is receiving the first generation MTC formula in very low dose. This is to make the real active dose pill and the placebo fake pill look and taste exactly the same, including for possible urine discolouration side effects. 18 years ago when I invested in Taurx, private equity investors will joking call this the "Blue Pee Pill". I think there could be some minority cases of minor positive drug effect here even at low dose MTC formula. It is very difficult to formulate a placebo fake pill that looks, taste and pee out in blue like the real pill.

Now I think the real trial result to be announced is going to be below my expected trial result score. This placebo pill become active dose is not a new issue. Taurx experienced this problem before back in 2016 when placebo pill HMTM 4mg was later discovered to be an active dose with powerful drug effects. Because of this placebo pill issue, the entire phase 3 clinical trial failed. I have mentioned abt this before in my earlier post. At that time, Taurx failed to realise that HMTM is actually 60 times the power of MTC formula. They thought its was like 30% more powerful than MTC. Some gross miscalculation then, very painful lesson learned, US$200m trial cost burned just like that, lost 6 years of drug development time.

Posted by Income > 3 hours ago | Report Abuse

I think the results will be middle ground… not too good and not too bad. So Moderate or to be exact 50% efficacy of Taurx. So, Any impact from this 50% efficacy on Genting?

So the most Genting will get out of Taurx is another 20 to 30 sen upside. My 2 sen opinion
------------------------------------------------------

Excellent Lucidity trial results has been largely priced in GentB's share price already. Read the trial announcement:

"....participants receiving HMTM decline at a rate substantially less than is typical in Alzheimer’s based on published research. This was seen for both cognitive and functional endpoints across a broad range of severity from mild cognitive impairment (MCI) to moderate Alzheimer’s. Importantly, the safety profile is favourable and consistent with previous studies."

Heng got Taurx news to boost up the share price. Without Taurx news, GentB will probably be trading at 4.50 or even back to 4.30 support zone with the shocking Q1 result.

Lucidity Trial has 3 primary end points, 7 secondary end points. Primary endpoints are the most important in any clinical trial. Any primary endpoint fail means non-negotiable trial failure.

Looking at Lucidity's secondary end point item 1-> Rate of decline for brain atrophy. This measurement speaks a lot of volume on drug's performance. AD patients suffer from severe brain shrinkage due to death of brain neurons. Imagine a healthy sea coral's volume vs dried up coral volume. If the brain shrinks at a slower rate, that means brain neurons are dying at a slower rate. The drug is doing its job in slowing down brain neurons death, slowing down disease progression.

https://clinicaltrials.gov/ct2/show/NCT03446001



Here are some of the competitors' phase 3 clinical trial status:

https://www.clinicaltrials.gov/ct2/show/NCT03887455

https://clinicaltrials.gov/ct2/show/NCT04437511

https://www.clinicaltrials.gov/ct2/show/NCT03443973


Do you notice how come all the others are using these newly invented kelong primary endpoints, hopefully the FDA will view their "easier to attain" score more favourably?
-Change from Baseline in the CDR-SB
-Change From Baseline to Week 116 in Global Outcome, as Measured by Clinical Dementia Rating-Sum of Boxes (CDR-SOB)
-Change from Baseline on the integrated Alzheimer's Disease Rating Scale (iADRS)

Taurx still still using the traditional gold standard primary endpoint measurement used for the past 20 years. We are the real deal. No need to change into wider kelong goal post.
- Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-cog11)
- Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL23)

Confirm more than 50% for ADAS-COG11 primary endpoint. The other primary endpoint is ADL lifestyle will be lower than cognition score. Very difficult to pass ADL (lifestyl)e. Many new clinical trials shift their goal post to lower standard of endpoint measurements. The traditional style of endpoint measurements, those taurx is using, are the gold label measurement standards. But all the drug manufacturers find it impossible to pass. Hence they using kelong lower standard of measurements.

Slowdown by 90% is effectively almost halting disease progression. Super lityle decline. Remember the bar is so low that slowdown by 25% can pass trial liow. So far all other competitors' disease modifying drugs failed.

Slowdown by 50% means the HMTM drug patient is declining at half the rate when compared to non-HMTM patients.

Thats why under such environment got profits from long positions safer to lock in some first. You never know when the next mkt selldown will come. My stock trading sifu in jan this yr already said mkt has peaked n started shorting.

https://www.thestar.com.my/business/business-news/2022/06/02/interest-in-genting-spurred-by-progress-in-alzhemier039s-treatment


RHB analyst... OMG!

Sorry but i disagree. Drugs must go thru phase 3 trials before submission to regulators for approval.

If can show a slowdown of abt 25% can pass trial liow. Anything that can slowdown by 50% is a very credible wonder drug. Mind you this is a phase 3 trial. Aduhelm did not even complete their phase 3 trial n FDA approved them. This is so ridiculous!

Posted by cktay > 2 hours ago | Report Abuse

So hopefully, TauRx will be fast-tracked to take over Biogen’s drug.

----------------------------------------------------------------

Biogen's Aduhelm (F.K.N. Aducanumab) is commercially dead. FDA's neuro department is currently under federal investigation for corruptly approving Aduhelm. Huge controversy and fiasco one year ago when FDA gave Biogen "Accelerated Approval" using unproven science of clearing Amyloid deposits as biomarkers.

Biogen and Eisai are putting all their hopes on their next AD drug Lecanumab (BAN2401). Phase 3 result shd be out in 2022 Q4.

Posted by emsvsi > 1 day ago | Report Abuse

Dundee Corp. Class A
https://g.co/kgs/HePp6s
----------------------------------------

They own 4% of TauRx but wrote-off their TauRx investment. Now discover there are diamonds inside their thrash bin. How to buy this Toronto listed stock? The usual brokerage firm that I'm using cannot make it for TSX stocks.

https://www.dundeecorporation.com/holdings/major-investments/default.aspx

Legacy Investments
Company Ownership
Agrimarine 100%
Blue Goose 89.0%
United Hydrocarbon International Corp. 84.0%
Android Industries 20.0%
Tau-Rx 4.0%

Posted by WinSSP > 4 hours ago | Report Abuse

Yes, more peaceful if without fake trader atk long yappings
-------------------------------------------------------------

These are your fakes trades. You kena dementia already? I will keep reminding you. You need help to enroll yourself into Taurx compassionate program? I think they will reject you LoseSSP because you tell a lot of lies here and obviously not compassionate person. Kekeke....



Posted by Stocksafeplayer > Mar 19, 2021 4:25 PM | Report Abuse

Congrats.......
My average is 4.50....Super grateful aldy!!
-----------------------

Posted by Stocksafeplayer > Apr 21, 2021 5:45 PM | Report Abuse

My average is 4.20....4.68 too expensive la
----------------------

Posted by Stocksafeplayer > Sep 1, 2021 4:31 PM | Report Abuse

Average 4.00…. at 5.05… already more than 250k profit on paper… heng ahh!

------------------------

Posted by shareinvestor888 > Jan 27, 2022 6:39 PM | Report Abuse

I bought GenB at 3.50…. Very happy….

Posted by Income > 1 minute ago | Report Abuse

Sifu ATK,
Aunty WinSSP, also very free to finding faults of other people here. She suggested all Uncles and Aunties not to chat until midnight and to find friends.
She even wanted to comment about me when I tried to talk to VirusT. I am shocked why she is a very Busybody fellow.
No wonder she has lots of enemies here
----------------------------------------------------

If I remember correctly, some glovers complain abt her rubbish postings in i3 to glove companies like Top Glove. Hence she has to change new ID to avoid being tracked down and sued. She is the infamous cha cha aunty STOCKSAFEPLAYER. Those readers that have been here for a long time will know abt her past behaviour. It was really bad a year ago. Everyday vulgarities. Now considered very peaceful liow.

Can cha cha aunty share with us what is your latest GenB average price? Let me guess.... I think most likely rm3.00 now after seeing @Sharefisher's average price was rm3.10. Lo......serSSP. Kekeke.....

Posted by WinSSP > 31 minutes ago | Report Abuse

follow kaki bodek 1bodek1…. Hahaha
-----------------------------------------------

As usual. cha cha aunty nothing useful to contribute here except auto lowering her GenB's average price. Kekeke....

To Professor Claude Wischik,

It has been a privilege and honor to soldier on with you all these years.
Thank You!


https://www.youtube.com/watch?v=leQ_DpVnfdw

Who said LKT is a prodigal son? I think LKT, like ATK, made a well calculated risk-return bet on Taurx Pharmaceuticals Ltd. ATK went in Taurx at US$0.125B valuation. LKT went in Taurx at US$0.56B valuation.

TauRx is the biggest drug story success of the 21st century. Against all odds. Soldier on with courage and determination. Finish up that phase 3 trial and show the AD field that Science is proven in clinical trials, not in politics.

I am waiting for Nobel Prize (Medicine) to be awarded to Professor Claude Wischik some time down the road.

Cannot compare HMTM (an oral drug that is super effective with zero risky side effects) VS Aduhelm (intravenous drug that did not work, plus 40% dangerous side effects ARIA cases -> brain swelling and bleeding).


https://www.fiercepharma.com/pharma/biogen-s-56k-price-tag-for-alzheimer-s-drug-aduhelm-worth-it-watchdog-says-try-more-like-8

Posted by cktay > 6 minutes ago | Report Abuse

The Phase 2 trial …. 321 patients with an earlier version of the drug showed a 90% reduction in the rate of disease progression over two years.
The result was supported by functional brain imaging.
(Imaging identified the regions within the brain known to be affected by Alzheimer’s neuropathology that were protected by the drug)
…. “reduce clinical decline and brain atrophy by about half over 12 months”
Phase 2 results were already highly significant!
-------------------------------------------------------

Thats the "REMBER" phase 2 trial completed somewhere in 2008 under the first generation drug formula MTC. But MTC formula is highly inefficient and did not work well at high dose. The 2nd generation formula HMTM is very efficient, 60 times the absorption rate into our blood brain barrier compared to the same dosage under MTC formula. Too efficient until the placebo 4mg twice daily was actually an active dose. Both arms of trial patient groups receiving active doses. Hence Taurx failed their Phase 3 trials back in 2016 due to dosage issues. Cost us USD200m plus a 6 years delay in re-trial.

Posted by WinSSP > 1 hour ago | Report Abuse

wannabe boss of genting forum 2Invest2…. cakap manyak
---------------------------------------------------

If Cha Cha aunty has been using the same I.D. stocksafeplayer and didn't delete so many of her old posts, I estimate she would have made over 100,000 posts by now. Confirm i3 will crown her the boss of GentB forum. Anyone here knows why cha cha aunty likes to change her I.D? Is it her old I.D being monitored by some authorities?

Posted by WinSSP > 7 minutes ago | Report Abuse

Boring day….2 old fellas yapping long-long …. macam pandai sangat
------------------------------------------------------------

Confirm younger than you la cha cha aunty. Staying alive, Saturday Night Fever.... Kekeke... Baby boomers' music and movie.

I listen to DJ Tiesto :)

I hope Taurx can a slot to present at AAIC San Diego. Claim the victory in USA soil at the amyloid camp's HQ.

In the late 1980s, Professor Claude Wischik and his teacher at Cambridge Professor Sir Martin Roth already knew Tau is the driver of AD and not Amyloid. They have a mini brain bank in their Cambridge lab, abt 300 donated brains from deceased patients. Slice up the brain cross section and study it under microscope. All the results clearly show that brains with tau tangles were demented as per the health record of the deceased, brains without tau tangles were not demented. This is against the theory of the most widely accepted Amyloid hypothesis. Amyloid deposits are inconclusive whether the patient is demented or not. There are patients with brain full of amyloid but not demented, there are patients with no amyloid in their brain but they are demented.

Late 1990s, Professor Claude discovered a compound called methylene blue is able to dissolve tau tangles very effectively. From late 1990s to 2022, it took us abt 25 years to prove the effectiveness of this drug compound in a phase 3 trial. A quarter century!

These days we don't have to slice up donated brains and look under microscope. The huge advancement in brain PET scan technology on life patients clearly concludes that spreading of Tau tangles is the main culprit and driver of AD. In the face of these hard facts and truth, we still have the vast majority of the clinical trials devoting to targeting amyloid deposits, still in denial that Tau is the main culprit of AD.

We are the pioneer of Tau based treatments in the AD field and TauRx is truly light years ahead of all the competitors. I will expect naysayers from the amyloid hypothesis camp to continue to discredit us. They will also come up with something like "targeting tau looks ok, but targeting both tau and amyloid will work even better". Of course the amyloid camp professors will try to save their livelihood even with hard facts that show their decades of neurology studies / expertise are total rubbish and won't work. If amyloid theory is correct, they would have come out with a drug that can work long ago. Politics at science is delaying the advancement of AD research, hence we haven't got a drug that can work...... until yesterday's phase 3 clinical trial result.

Posted by SinGor > 1 hour ago | Report Abuse

TauRx is promising but very small trial sample. Need another 7--10years to get FDA approval even large
scale Trial was done yesterday......Better hope Covid is Gone and Customers return to Betting
----------------------------------------------------

This is the only phase 3 trial which can see significant slowdown in decline for a disease modifying AD drug. Nobody has done it before and nobody is able to do it for the next 10 years. The smaller the trial population, the harder it is to show statistical significance. Hence those iffy drugs done by large pharmas will try to do very large patient size trial to improve the statistical significance score. Before we do the clinical trial design, we already have an estimated drug performance benchmark using knowledge from previous clinical trials. Then need to show it in a new clinical trial by powering it with the number of trial patients using computer simulated graphs. Our earlier computer simulation estimated abt 400 patients is sufficient to show strong statistical significance figure due to the extremely powerful drug effect of HMTM. To be safe, increase the patient population by 25% to 500 patients.

Further cost cutting measures such reducing the number of trial centres by half can yield significant cost savings and allowed us to increase the patient population to almost 600 patients.

Taurx 0.7% shareholder here. Dont badmouth my company. This drug is the real deal. The first disease modifying drug that can significantly slowdown disease progression in a phase 3 trial. I can talk a lot of Alzheimer’s drug industry landscape, tau vs amyloid theory, taurx valuation, competitors, etc. I know the real valuation of taurx.

Posted by Income > 14 seconds ago | Report Abuse

Wow Sifu ATK, lots of Luck to your holding Taurx.
----------------------------------------------------

I know a lot of trial patients and their care givers. I even search thru blogs and online to contact overseas trial patients to find out how they are doing. I even recommended local patients through their care givers to enrol into Taurx's local compassionate program. Almost all the patients see very good results.

When tens of millions are on the line, better make very very sure the groundwork study is solid before putting the money down.

Mar 25, 2022 1:33 PM | Report Abuse

Posted by emsvsi > 58 minutes ago | Report Abuse

YES VENTURECAPITALINVESTOR IF YOU LIVE LONG ENOUGH AND GO THROUGH (FORUM) HISTORY YOULL UNDERSTAND !
-----------------------------------

Yes venture capital investment needs a lot of conviction. I just more than doubled my position in a biotech unicorn a few months ago until I own abt 0.7% of the company. The biggest bet of my life..... to save the world from devastating diseases and to make some serious money from it! :)
-----------------------------------------------------------------------------------------


**********************************
TAURX PHARMACEUTICALS LTD
**********************************

The Singapore based company where this south wind tornado originates.

Im proud to be the very first round (Series A) investor when valuation was USD0.125B after successful mouse trial back in 2004. Along the way I added positions, the final showhand amount was during the rights cum attached warrant issue only 7 months ago.

After 18 long years, numerous rounds of fund raising including 2012 GentB investment and 3 rounds of rights issue, this is conviction to the max. David beats Goliath. WE FREAKING MADE IT FINALLY!!!!!!

Posted by Income > 1 hour ago | Report Abuse

Ahh yoohhh. No news today. Big news tomorrow???
I sold 50% of my tickets already. I am a small Bilis here.

Sifu ATK, do you still have holding here?
---------------------------------------------------

As usual, good to lock in profits along the way. Keep some balance. Safety first. GentB is a small tiny fraction of my earnings only. Make or dont make its ok. The main bulk of my earnings is with Professor Claude Wischik.

How james bond 007 soong or not? I even said until professor claude wischik yesterday. But cha cha aunty said i talk irrelevant stuff. Ownself buy ownself make lor. Huat!!!

Posted by WinSSP > 17 minutes ago | Report Abuse

Non-genting shareholders always welcomed to share views or latest related news here! We all just ignore the 1 fake trader who brag everyday.
----------------------------------------------------------

You are too dumb. Too bad. You like to cut out what I have to say. Hard to share good trading skills and knowledge. Cha Cha Cha!

LKT is not dumb. He is a genius like ATK. Soon you will know his power!

Professional cha cha dance bought big yesterday late afternoon and this morning.

Posted by Sharefisher > 1 hour ago | Report Abuse

Destinyl, don't talk behind me lah.... I still read this forum lah... Just not so nice to comment when I don't hold genting share now. 4.73(average) - 3.105(after dividend) =.......... Uncle very happy lah.... Cheers.
-------------------------------------------------------------

@Sharefisher huat leh. Average price 3.10 is super good. Very happy for you!

Not like some fake investor here. Her average price auto drop by huge amount frequently even though GentB share price did not trade lower for her to average down. Kekeke....

Posted by WinSSP > 2 minutes ago | Report Abuse

Congrats Sharefisher! We all happy for you la. Cos genuine news mah ….unlike that long im-poster
-------------------------------------------------------------

Cha Cha aunty referring abt herself? Haha....ha.... so funny



Posted by Stocksafeplayer > Mar 19, 2021 4:25 PM | Report Abuse

Congrats.......
My average is 4.50....Super grateful aldy!!

------------------------------
Posted by Stocksafeplayer > Apr 21, 2021 5:45 PM | Report Abuse

My average is 4.20....4.68 too expensive la

-------------------------------
Posted by Stocksafeplayer > Sep 1, 2021 4:31 PM | Report Abuse

Average 4.00…. at 5.05… already more than 250k profit on paper… heng ahh!

--------------------------------
Posted by shareinvestor888 > Jan 27, 2022 6:39 PM | Report Abuse

I bought GenB at 3.50…. Very happy….

Posted by WinSSP > 34 minutes ago | Report Abuse

nobody asking you to comment so long la. Be like @ JBond, always share latest news la
-------------------------------------------------------------

A lot of jealous and unkind people here. No point for a professional cha cha dancer to share trading skills and knowledge here. Cha Cha Cha!

Posted by JBond007 > 4 hours ago | Report Abuse

From Scotland with Love.......The LUCIDITY Study.
https://www.luciditytrial.com/
------------------------------------------------------

Professor Claude Wischik and Dr K.M Seng (deceased). I know them since 18 years ago. Every time Claude comes to Singapore, he will stay at Regent Singapore.

The venture capitalist industry is quite vibrant in Singapore. When you are also an active private equity investor, you will know some of these companies' founders.

Posted by WinSSP > 2 hours ago | Report Abuse

not sure if alot less fun without sharefisher etc. Definitely alot more fun without those mini fake traders bragging making profits here n there lol.
--------------------------------------------------------------------------

Real become fake, fake become real? Eating sour grapes stocksafeplayer LoseSSP? We really like your fake trades that you posted here. Cha Cha aunty dont leave also ok? We are all enjoying how shamelessly you are making a fool out of yourself here. Kekeke.....


Posted by Stocksafeplayer > Mar 19, 2021 4:25 PM | Report Abuse

Congrats.......
My average is 4.50....Super grateful aldy!!

------------------------------
Posted by Stocksafeplayer > Apr 21, 2021 5:45 PM | Report Abuse

My average is 4.20....4.68 too expensive la

-------------------------------
Posted by Stocksafeplayer > Sep 1, 2021 4:31 PM | Report Abuse

Average 4.00…. at 5.05… already more than 250k profit on paper… heng ahh!

--------------------------------
Posted by shareinvestor888 > Jan 27, 2022 6:39 PM | Report Abuse

I bought GenB at 3.50…. Very happy….

Posted by Sharefisher > 3 hours ago | Report Abuse

Thanks genting and bye genting.
-----------------------------------------------

Ooi old friend @Sharefisher don't leave leh. Here a lot less fun without you! There will always be opportunities here, sweet GentB honey waiting to be extracted.

Posted by WinSSP > 17 seconds ago | Report Abuse

fake trader with no holding power… cakap manyak sini, always long postings lol
---------------------------------------------------------------------------------------

Fake investor doing Cha Cha Cha dance on her i3 postings? Post then delete, then post and delete again. Kekeke...

Posted by WinSSP > 17 minutes ago | Report Abuse

fake trader again with no holding power… cakap manyak sini, always long postings lol
-----------------------------------------------------------------------------------------------


Fake investor like to talk abt her average price 4.50, 4.20, 4.00, 3.50, etc..., aunty going to top up now, etc.

To be a good trader and win real money from the stock market, you need to trade with your eyes open, recognise real trends and turns, and most importantly not wasting time with delusional wishful thinking.

_

Posted by Sharefisher > 2 days ago | Report Abuse

Haha ha.. Angtaykor, good for you... But I still happy with my genting investment. Not as much as you make, but enough for me.
------------------------------------------------------------

My 3rd successful GenB trade for this year. Cha Cha Cha! :)

We are in the stock market to win real money, not see who got better holding power can hold the stock longer.